Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin54.8%-3.7pp53.5%-6.6pp51.4%-7.9pp59.4%-0.1pp58.5%-7.8pp
Efficiency
Asset turnover+0.1×+0.2×0.0×0.9×-0.1×0.8×-0.4×
Liquidity
Current ratio1.2×-0.8×1.6×-0.5×1.6×+0.1×1.8×+0.4×+0.4×
Leverage
Debt-to-equity-0.2×1.2×0.0×1.3×+1.1×1.3×+0.9×1.2×+0.9×
Valuation
Market capitalization$930.79M+156%$453.48M+30.7%$582.75M+276%$364.45M+331%$348.09M+261%
Price / sales10.7×+3.2×5.7×-3.2×8.3×+3.8×6.3×+3.6×7.2×+4.4×
Price / book30.4×+15.5×17.3×+3.1×25.2×+15.5×15.2×+8.9×14.2×+8.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Eton Pharmaceuticals, Inc.'s profit margins?
Eton Pharmaceuticals, Inc. (ETON) runs a 54.8% gross margin and a -15.1% operating margin, with a -9.5% net margin.
Where do Eton Pharmaceuticals, Inc.'s ratios come from?
Every ratio is computed from Eton Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.